SCHEMBL8950606

SCHEMBL8950606

COc1ccc(N2C(CO)=Cc3ccsc3S2(=O)=O)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
GAA P10253 2/20 0.34
RXFP1 Q9HBX9 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 2/20 0.33
P2RX7 Q99572 1/20 0.33
KMT2A Q03164 2/20 0.32
HTT P42858 1/20 0.32
GFER P55789 1/20 0.32
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
MAPK8 P45983 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8950208 0.81 CA2 (0.33) CA2CA4
SCHEMBL8950361 0.80 LMNA (0.38) CA2NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL22309076 0.56 ALDH1A1 (0.49) RAB9AMAPTALDH1A1P2RX7KMT2A
1,4-Dimethoxybenzene SCHEMBL28544369 0.55 CA1 (0.69) CA2GAANPC1RAB9AMAPT
SCHEMBL10515467 0.54 NPC1 (0.57) CA2GAANPC1RAB9AMAPT
SCHEMBL6358558 0.54 CA12 (0.53) CA2NPC1RAB9AMAPTKMT2A
SCHEMBL27329 0.54 IDO1 (0.58) CA2SMN1; SMN2ALDH1A1HTTCYP3A4
SCHEMBL4181089 0.54 IDO1 (0.58) CA2SMN1; SMN2ALDH1A1HTTCYP3A4
SCHEMBL717969 0.53 RAB9A (0.61) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL23728137 0.53 ALDH1A1 (0.42) CA2GAANPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5538966-A ENZYME INHIBITORS FOR TREATMENT OF GLAUCOMA ALCON LABORATORIES, INC. (US) 1996-07-23 US disclosed